Lam Opal Huang

Lam Opal Huang

Auto-generated profile, based on publicly available information

Lam Opal Huang

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
LHLam O. Huang
Lam O. Huang
ARAlexander Rauch
Alexander Rauch
EMEugenia Mazzaferro
Eugenia Mazzaferro
MPMichael Preuss
Michael Preuss
SCStefania Carobbio
Stefania Carobbio
RLRuth J. F. Loos
Ruth J. F. Loos

15 December 2012 in Human Genetics
Verified
Journal Article
Closed access
PDF file
LHLam Opal Huang
Lam Opal Huang
ALAurélie Labbe
Aurélie Labbe
CIClaire Infante-Rivard
Claire Infante-Rivard

1 March 2018 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
LHLam Opal Huang
Lam Opal Huang
RLRuth J. F. Loos
Ruth J. F. Loos
TKTuomas Oskari Kilpeläinen
Tuomas Oskari Kilpeläinen
Obesity has evolved into a global pandemic that constitutes a major threat to public health. The majority of obesity-related health care costs are due to cardiometabolic complications, such as insulin resistance, dyslipidemia, and hypertension, which are risk factors for Type 2 diabetes and cardiovascular disease. However, many obese individuals, often called metabolically healthy obese (MHO), seem to be protected from these cardiometabolic complications. Conversely, there is a group of individuals who suffer from cardiometabolic complications despite being of normal weight; a condition termed metabolically obese normal weight (MONW). Recent large-scale genomic studies have provided evidence that a number of genetic variants show an association with increased adiposity but a favorable cardiometabolic profile, an indicator for the genetic basis of the MHO and MONW phenotypes. Many of these loci are located in or near genes that implicate pathways involved in adipogenesis, fat distribution, insulin signaling, and insulin resistance. It has been suggested that a threshold for subcutaneous adipose tissue expandability may be at play in the manifestation of MHO and MONW, where expiry of adipose tissue storage capacity could lead to ectopic lipid accumulation in non-adipose tissues such as liver, muscle, heart, and pancreatic beta cells. Understanding the genetic aspects of the mechanisms that underpin MHO and MONW is crucial to define appropriate public health action points and to develop effective intervention measures.

1 June 2020 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
SMSophia Metz
Sophia Metz
LHLam Opal Huang
Lam Opal Huang
TKTuomas O Kilpeläinen
Tuomas O Kilpeläinen

31 August 2016 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
LHLam O. Huang
Lam O. Huang
CIClaire Infante-Rivard
Claire Infante-Rivard
ALAurélie Labbe
Aurélie Labbe
Transmission of the two parental alleles to offspring deviating from the Mendelian ratio is termed Transmission Ratio Distortion (TRD), occurs throughout gametic and embryonic development. TRD has been well-studied in animals, but remains largely unknown in humans. The Transmission Disequilibrium Test (TDT) was first proposed to test for association and linkage in case-trios (affected offspring and parents); adjusting for TRD using control-trios was recommended. However, the TDT does not provide risk parameter estimates for different genetic models. A loglinear model was later proposed to provide child and maternal relative risk (RR) estimates of disease, assuming Mendelian transmission. Results from our simulation study showed that case-trios RR estimates using this model are biased in the presence of TRD; power and Type 1 error are compromised. We propose an extended loglinear model adjusting for TRD. Under this extended model, RR estimates, power and Type 1 error are correctly restored. We applied this model to an intrauterine growth restriction dataset, and showed consistent results with a previous approach that adjusted for TRD using control-trios. Our findings suggested the need to adjust for TRD in avoiding spurious results. Documenting TRD in the population is therefore essential for the correct interpretation of genetic association studies.